5.000
+4,17%
2026-10-19
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +109.7% | -124.5% | 2 / 3 | +123.0% | +2.23 pp | -0.72 pp | +5.8% | 0.33 | 7.15 | 42,1 | +123,0% | 4,3 | +108,2% | 7.15 | 12.40 | −42,3% |
| Pts | 12 | 0 | 8 | 12 | 8 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 5.000 (close price on 2026-10-19)EPS (TTM): 699,0
Financial charts
1.Revenue & growth
VND bn42,1Q2/26
1.Revenue & growth
VND bn42,1Q2/26
2.Profit & growth
VND bn4,27Q2/26
3.Profit mix (Penman)
VND bn8,92Q2/26
4.Margins & cost structure
%9.9%Q2/26
5.Returns & cash cycle
% · days2.8%Q2/26
6.Earnings quality & cash
VND bn-1,69Q2/26
7.Asset structure
VND bn217Q2/26
8.Funding & debt health
VND bn · times217Q2/26
9.Revenue backlog
VND bn6,55Q2/26
10.Valuation
times · %7,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %428Q2/26
Adjusted EPS growth, latest quarter
110%
Average adjusted EPS growth, 3 quarters
-124%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26